Meet and Greet with the National Cancer Institute (NCI)

When Thursday, August 26, 2010
8:00 a.m. - 12:30 p.m.
Add to Calendar

RSVP by Wednesday, August 25, 2010 12:00 p.m.
Where Mintz Levin-San Diego
3580 Carmel Mountain Road Suite 300
San Diego, CA 92130




Meet and Greet with the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Development Leadership and learn how you can tap into $11 million in new funding opportunities

Are you interested in learning more about funding opportunities to help your small business or research institution advance an innovative cancer technology? BIOCOM is providing a unique opportunity for members to meet with leaders from the National Cancer Institute (NCI) Small Business Research (SBIR) Development Center. Join us in a discussion about upcoming SBIR contract and grant funding opportunities, the Phase II Bridge Award, and get tips for applying.

Also learn about new programs that NCI has launched to support its SBIR companies in moving their technologies towards the marketplace. These include the NCI SBIR Investor Forum to be held November 9th, 2010 at Stanford University. This is a unique opportunity for NCI's top SBIR firms to showcase their companies to investors. NCI will also describe its new SBIR Regulatory Assistance Program.

Following a group presentation, BIOCOM members will have an opportunity for private meetings with Michael Weingarten, Director of the NCI SBIR Development Center, or Ali Andalibi, Branch Chief of the SBIR Development Center with responsibility for therapeutics and diagnostics.

There are many benefits to applying for NCI SBIR & STTR funding opportunities, such as:
•SBIR & STTR awards provide recognition, verification, and visibility
•SBIR & STTR funding can be a leveraging tool to help attract additional funding from other third-party investors
•Awards are not loans; no repayment is required
•SBIR & STTR funding is non-dilutive capital (i.e., an award does not impact the company's stock or shares in any way). Intellectual property rights to technologies developed under these programs are retained by the small business concern.

Speakers:
Michael Weingarten, Director, NCI SBIR Development Center, National Cancer Institute
Michael Weingarten is the Director for the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute, one of 27 Institutes of the National Institutes of Health (NIH) in Bethesda, Md. In this role, Mr. Weingarten manages all aspects of the NCI SBIR and Small Business Technology Transfer (STTR) programs including a portfolio of over $100M in grants and contracts annually. The SBIR and STTR programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.  In his current role, Mr. Weingarten led a team that developed a set of key recommendations for optimizing the performance of the NCI SBIR program at the NIH. Those recommendations included the establishment of an SBIR Development Center to manage the NCI SBIR program. This Center is staffed with talented leaders from both industry and the NIH who have expertise in the development and commercialization of technology in the cancer field to optimize the returns the NCI achieves through this program.

Ali Andalibi, Ph.D., Program Director, NCI SBIR Development Center, National Cancer Institute
Dr. Ali Andalibi is a molecular biologist and geneticist by training with extensive experience in both academia and industry. He received his PhD from the UCLA department of Microbiology and Molecular Genetics and later joined the faculty in the UCLA department of Medicine. After leaving UCLA he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI), where he served as the Director of New Technology and Project Development and was also an adjunct Assistant Professor of Otolaryngology, at the University of Southern California, School of Medicine. Dr. Andalibi then joined the National Science Foundation as a Program Director in the Division of Industrial Innovation and Partnerships, where he oversaw the NSF's medical biotechnology SBIR/STTR grant portfolio. Dr. Andalibi is currently a Program Director in the National Cancer Institute's SBIR Development Center, where he leads the Therapeutics Cluster.

Scott R. Pancoast, President, Chief Executive Officer and Director, Lpath Inc.
Mr. Pancoast has served as the President and Chief Executive Officer of Lpath since March 2005, and as a Director of Lpath since 1998. Prior to joining Lpath, from 1994 to 2005 Mr. Pancoast was the Executive Vice President of Western States Investment Corporation (?WSIC?), a private San Diego venture capital fund. He has served as the CEO or interim CEO for six start-up companies, and has been a member of the board of directors for over 15 companies, including two public companies. During 2005 and 2006 Mr. Pancoast continued to serve as the Executive Vice President of WSIC, which is co-owned by two of Lpath?s largest stockholders. Lpath was reimbursed by WSIC for the portion of his compensation and benefits corresponding to the time he devoted to WSIC matters. Effective December 31, 2006, Mr. Pancoast resigned from his position as an officer and director of WSIC; however, he continues to serve as a member of the board of directors of four WSIC portfolio companies. From 1986 to 1994 Mr. Pancoast was with National Sanitary Supply Company, where he was a member of the Board of Directors and served in various management positions including Senior Vice President?Operations and Chief Financial Officer. Mr. Pancoast currently serves on the board of Sound Health Solutions, Inc. [SHSO.PK]. He is a graduate of the Harvard Business School and the University of Virginia. We believe Mr. Pancoast?s qualifications to sit on our Board include his experience as a CEO, his experience as a venture capitalist and business leader, and his current and past service as a board member for public and private companies.

Following this workshop, there will be a potential opportunity for BIOCOM members to schedule private meetings with Mr. Michael Weingarten, the Director of the NCI SBIR Development Center, or Dr. Ali Andalibi, the Program Director of the NCI SBIR Development Center.

About the National Cancer Institute SBIR Development Center: SBIR &STTR Programs
The SBIR & STTR Programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-asides for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.


Click here to access full event schedule.


Directions to Mintz Levin Offices:

From the South (e.g. Lindbergh Field)
• Take I-5 North to the Local (I-805) Bypass (on the right just past Genesee Road)
• Exit at Carmel Mountain Road
• At the end of the off ramp turn right (East) onto Carmel Mountain Road
• Immediately at the first signal light (one-half block) turn left on Gateway Ridge Court
• Mintz Levin is in the second building (# 3580). Make sure to turn right at the second driveway and pull into the parking structure.

From the North (e.g. Orange County)
• Take I-5 South to the Local (I-805) Bypass (on the right just past Carmel Valley Road)
• Exit at Carmel Mountain Road
• At the end of the off ramp turn left (East) onto Carmel Mountain Road
• Proceed under the freeway and, at the second signal light, turn left on Gateway Ridge Court
• Mintz Levin is in the second building (# 3580). Make sure to turn right at the second driveway and pull into the parking structure.

From the East (e.g. Riverside)
• Take I-15 South to Hwy 56 (Ted Williams Parkway)• Proceed West on Hwy 56, which will turn south just past El Camino Real and merge onto the Local (I-5/I-805)  Bypass
• Exit at Carmel Mountain Road (on the right just after Hwy 56 merges into the Bypass to I-5/I-805)
• At the end of the off ramp turn left (East) onto Carmel Mountain Road
• Proceed under the freeway and, at the second signal light, turn left on Gateway Ridge Court
• Mintz Levin is in the second building (# 3580). Make sure to turn right at the second driveway and pull into the parking structure.

Parking:
Parking is available in the building parking garage free of charge.

Get Driving Directions